Intensity Therapeutics Profit Margin

Intensity Therapeutics (INTS) currently reports a profit margin of 41126.92% as of March 2026. That is above the sector sector average of 19.61%. Use the charts on this page to explore Intensity Therapeutics's profit margin history and peer comparisons.

Intensity Therapeutics's profit margin of 41126.92% is higher than the its sector sector average of 19.61%. That is roughly 209660.2% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Intensity Therapeutics's current 41126.92% should be judged against industry norms (sector average: 19.61%) and against INTS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 41126.92%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 19.61%. From there, open related valuation or income-statement pages for Intensity Therapeutics, and consider following INTS for alerts when major investors trade the stock.